Real world data on cardiometabolic diseases in U.S. adults during the SARS-CoV-2 pandemic: a decentralized registry study.

Parth Shah¹, Kim Magee², Kiara H Buccellato², McKenna Ismond², Jalisa Watson²

¹ObvioHealth, 3452 Lake Lynda Dr., Bld. 100 Ste 151, Orlando, FL, 32832, USA. parth.shah@obviohealth.com.

²ObvioHealth, 3452 Lake Lynda Dr., Bld. 100 Ste 151, Orlando, FL, 32832, USA.

Abstract

BACKGROUND: Pre-existing cardiometabolic comorbidities place SARS-CoV-2 positive patients at a greater risk for poorer clinical course and mortality than those without it. We aimed to analyze real-world registry data focused primarily on participants with cardiometabolic diseases (CMD), which were remotely obtained via a digital platform. METHODS: Participants were divided into two groups: CMD or…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free Account Sign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.